Mechanisms of neurotoxicity associated with amyloid β deposition and the role of free radicals in the pathogenesis of Alzheimer's disease: A critical appraisal

Chemical Research in Toxicology

Volumn 10, Issue 5, 1997, Pages 518-526

  Sayre, Lawrence M ^a   Zagorski, Michael G ^a   Surewicz, Witold K ^a   Krafft, Grant A ^b   Perry, George ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; FREE RADICAL;

AGING; ALZHEIMER DISEASE; APOPTOSIS; DOWN SYNDROME; HUMAN; NERVE DEGENERATION; NEUROTOXICITY; OXIDATIVE STRESS; PROTEIN AGGREGATION; PROTEIN SECONDARY STRUCTURE; REVIEW; SENILE PLAQUE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; FREE RADICALS; HUMANS;

EID: 0030983405     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx970009n     Document Type: Review

References (141)

1. Glenner, G. G., and Wong, C. W. (1984) Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890.
2. Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., and Beyreuther, K. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. U.S.A. 82, 4245-4249.
3. Suzuki, N., Cheung, T. T., Cai, X.-D., Odaka, A., Otvos, L., Eckman, C., Golde, T. E., and Younkin, S. G. (1994) An increased percentage of long amyloid β protein secreted by familial β protein precursor (βAPP717) mutants. Science 264, 1336-1340.
4. Gravina, S. A., Ho, L., Eckman, C. B., Long, K. E., Otvos, L., Jr., Younkin, L. H., Suzuki, N., and Younkin, S. G. (1995) Amyloid β protein (Aβ) in Alzheimer's disease brain. J. Biol. Chem. 270, 7013-7016.
5. Citron, M., Diehl, T. S., Gordon, G., Biere, A. L., Seubert, P., and Selkoe, D. J. (1996) Evidence that the 42- and 40-amino acid forms of amyloid β protein are generated from the β-amyloid precursor protein by different protease activities. Proc. Natl. Acad. Sci. U.S.A. 93, 13170-13175.
6. Klafki, H. W., Abramowski, D., Swoboda, R., Paganetti, P. A., and Staufenbiel, M. (1996) The carboxyl termini of β-amyloid peptides 1-40 and 1-42 are generated by distinct γ-secretase activities. J. Biol. Chem. 271, 28655-28659.
7. Teller, J. K., Russo, C., DeBusk, L. M., Angelini, G., Zaccheo, D., Dagna-Bricarelli, R., Scartezzini, P., Bertolini, S., Mann, D. M. A., Tabaton, M., and Gambetti, P. (1996) Presence of soluble amyloid β-peptide precedes amyloid plaque formation in Down's syndrome. Nat. Med. 2, 93-95.
8. Tamaoka, A., Kondo, T., Odaka, A., Sahara, N., Sawamura, N., Ozawa, K., Suzuki, N., Shoji, S., and Mori, H. (1994) Biochemical evidence for the long-tail form (Aβ1-42/43) of amyloid β protein as a seed molecule in cerebral deposits of Alzheimer's disease. Biochem. Biophys. Res. Commun. 205, 834-842.
9. Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Perez-tur, J., Hutton, M., Buee, L., Harigaya, Y., Yager, D., Morgan, D., Gordon, M. N., Holcomb, L., Refolo, L., Zenk, B., Hardy, J., and Younkin, S. (1996) Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature 383, 710-713.
10. Scheuner, D., Eckman, C., Jensen, M., Song, X., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., Larson, E., Levy-Lahad, E., Viitanen, M., Peskind, E., Poorkaj, P., Schellenberg, G., Tanzi, R., Wasco, W., Lannfelt, L., Selkoe, D., and Younkin, S. (1996) Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2, 864-870.
11. Hardy, J., and Allsop, D. (1991) Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol. Sci. 12, 383-388.
12. Iversen, L. L., Mortishire-Smith, R. J., Pollack, S. J., and Shearman, M. S. (1995) The toxicity in vitro of β-amyloid protein. Biochem. J. 311, 1-16.
13. Selkoe, D. J. (1996) Amyloid β-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271, 18295-18298.
14. Wisniewski, T., Ghiso, J., and Frangione, B. (1994) Alzheimer's disease and soluble Aβ. Neurobiol. Aging 15, 143-152.
15. Armstrong, R. A. (1995) A comparison of β-amyloid depostion in the medial temporal lobe in late-onset sporadic Alzheimer's disease and Down's syndrome. Amyloid: Int. J. Exp. Clin. Invest. 2, 107-113.
16. Maruyama, K., Tomita, T., Shinozaki, K., Kume, H., Asada, H., Saido, T. C., Ishiura, S., Iwatsubo, T., and Obata, K. (1996) Familial Alzheimer's disease-linked mutations at Val of amyloid precursor protein are specific for the increased secretion of Aβ42-(43). Biochem. Biophys. Res. Commun. 227, 730-735.
17. Games, D., Adams, D., Alessandrini, R., Barbour, R., Berthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., Guido, T., Hagoplan, S., Johnson-Wood, K., Khan, K., Lee, M., Leibowitz, P., Lieberburg, I., Little, S., Masliah, E., McConlogue, L., Montoya-Zavala, M., Mucke, L., Paganini, L., Penniman, E., Power, M., Schenk, D., Seubert, P., Snyder, B., Soriano, F., Tan, H., Vitale, J., Wadsworth, S., Wolozin, B., and Zhao, J. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373, 523-527.
18. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., and Cole, G. (1996) Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99-102.
19. Barrow, C. J., and Zagorski, M. G. (1991) Solution structures of β peptide and its constituent fragments: relation to amyloid deposition. Science 253, 179-182.
20. Fraser, P. E., Nguyen, J. T., Surewicz, W. K., and Kirschner, D. A. (1991) pH-dependent structural transitions of Alzheimer amyloid peptides. Biophys. J. 60, 1190-1201.
21. Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Menschen, A., Yates, J., Cotman, C., and Glabe, C. (1992) Assembly and aggregation properties of synthetic Alzheimer's A4/β3 amyloid peptide analogs. J. Biol. Chem. 267, 546-554.
22. Behl, C., Davis, J., Cole, G. M., and Schubert, D. (1992) Vitamin E protects nerve cells from amyloid β protein toxicity. Biochem. Biophys. Res. Commun. 186, 944-950.
23. Lorenzo, A., and Yankner, B. A. (1994) β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. U.S.A. 91, 12243-12247.
24. Pike, C. J., Walencewicz, A. J., Glabe, C. G., and Cotman, C. W. (1991) In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563, 311-314.
25. Pike, C. J., Burdick, D., Walencewicz, A. J., Glabe, C. G., and Cotman, C. W. (1993) Neurodegeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state. J. Neurosci. 13, 1676-1687.
26. Simmons, L. K., May, P. C., Tomaselli, K. J., Rydel, R. E., Fuson, K. S., Brigham, E. F., Wright, S., Lieberburg, I., Becker, G. W., Brems, D. N., and Li, W. Y. (1994) Secondary structure of amyloid β peptide correlates with neurotoxic activity in vitro. Mol. Pharmacol. 45, 373-379.
27. Camilleri, P., Haskins, N. J., and Howlett, D. R. (1994) β-Cyclodextrin interacts with the Alzheimer amyloid β-A4 peptide. FEBS Lett. 341, 256-258.
28. Howlett, D. R., Jennings, K. H., Lee, D. C., Clark, M. S. G., Brown, F., Wetzel, R., Wood, S. J., Camilleri, P., and Roberts, G. W. (1995) Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide. Neurodegeneration 4, 23-32.
29. Tomiyama, T., Shoji, A., Kataoka, K., Suwa, Y., Asano, S., Kaneko, H., and Endo, N. (1996) Inhibition of amyloid β protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger. J. Biol. Chem. 271, 6839-6844.
30. Ghanta, J., Shen, C.-L., Kiessling, L. L., and Murphy, R. M. (1996) A strategy for designing inhibitors of β-amyloid toxicity. J. Biol. Chem. 271, 29525-29528.
31. Wujek, J. R., Dority, M. D., Frederickson, R. C. A., and Brunden, K. R. (1996) Deposits of Aβ fibrils are not toxic to cortical and hippocampal neurons in vitro. Neurobiol. Aging 17, 107-113.
32. 1-42) and forms slowly sedimenting Aβ complexes that cause oxidative stress. Exp. Neurol. 136, 22-31.
33. Busciglio, J., Lorenzo, A., and Yankner, B. A. (1992) Methodological variables in the assessment of beta amyloid neurotoxicity. Neurobiol. Aging 13, 609-612.
34. Harrigan, M. R., Kunkel, D. D., Nguyen, L. B., and Malouf, A. T. (1995) Beta amyloid is neurotoxic in hippocampal slice cultures. Neurobiol. Aging 16, 779-789.
35. Giordano, T., Pan, J. B., Monteggia, L. M., Holzman, T. F., Snyder, S. W., Krafft, G., Ghanbari, H., and Kowall, N. W. (1994) Similarities between β amyloid peptides 1-40 and 40-1: Effects on aggregation, toxicity in vitro, and injection in young and aged rats. Exp. Neurol. 125, 175-182.
36. Jarrett, J. T., and Lansbury, P. T., Jr. (1993) Seeding "one-dimensional crustallization" of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055-1058.
37. Lomakin, A., Chung, D. S., Benedek, G. B., Kirschner, D. A., and Teplow, D. B. (1996) On the nucleation and growth of amyloid β-protein fibrils: Detection of nuclei and quantitation of rate constants. Proc. Natl. Acad. Sci. U.S.A. 93, 1125-1129.
38. Barrow, C. J., Yasuda, A., Kenny, P. T. M., and Zagorski, M. G. (1992) Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra. J. Mol. Biol. 225, 1075-1093.
39. Otvos, L. J., Szendrei, G. I., Lee, V. M. Y., and Mantsch, H. H. (1993) Human and rodent Alzheimer β-amyloid peptides acquire distinct conformations in membrane-mimicking solvents. Eur. J. Biochem. 211, 249-257.
40. Talafous, J., Marcinowski, K. J., Klopman, G., and Zagorski, M. G. (1994) Solution structure of residues 1-28 of the amyloid β-peptide. Biochemistry 33, 7788-7796.
41. Soto, C., Castaño, E. M., Frangione, B., and Inestrosa, N. C. (1995) The α-helical to β-strand transition in the amino-terminal fragment of the amyloid β-peptide modulates amyloid formation. J. Biol. Chem. 270, 3063-3067.
42. Gorévic, P. D., Castaño, E. M., Sarma, R., and Frangione, B. (1987) Ten to fourteen residue peptides of Alzheimer's disease protein are sufficient for amyloid fibril formation and its characteristic Xray diffraction pattern. Biochem. Biophys. Res. Commun. 147, 854-862.
43. Kirschner, D. A., Abraham, C., and Selkoe, D. J. (1986) X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-β conformation. Proc. Natl. Acad. Sci. U.S.A. 83, 503-507.
44. Kirschner, D. A., Inouye, H., Duffy, L. K., Sinclair, A., Lind, M., and Selkoe, D. J. (1987) Synthetic peptide homologous to β-protein from Alzheimer disease forms amyloid-like fibrils in vitro. Proc. Natl. Acad. Sci. U.S.A. 84, 6953-6957.
45. Shen, C.-L., and Murphy, R. M. (1995) Solvent effects on self-assembly of β-amyloid peptide. Biophys. J. 69, 640-651.
46. Dyrks, T., Dyrks, E., Hartmann, T., Masters, C., and Beyreuther, K. (1992) Amyloidogenicity of βA4 and βA4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J. Biol. Chem. 275, 18210-18217.
47. Snyder, S. W., Ladror, U. S., Wade, W. S., Wang, G. T., Barrett, L. W., Matayoshi, E. D., Huffaker, H. J., Krafft, G. A., and Holzman, T. F. (1994) Amyloid-β aggregation: Selective inhibition of aggregation in mixtures of amyloid with different chain lengths. Biophys. J. 67, 1216-1228.
48. Maggio, J. E., and Mantyh, P. W. (1996) Brain amyloid - A physicochemial perspective. Brain Pathol. 6, 147-162.
49. Hilbich, C., Kisters-Woike, B., Reed, J., Masters, C. L., and Beyreuther, K. (1992) Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease βA4 peptides. J. Mol. Biol. 228, 460-473.
50. Fraser, P. E., McLachlan, D. R., Surewicz, W. K., Mizzen, C. A., Snow, A. D., Nguyen, J. T., and Kirschner, D. A. (1994) Conformation and fibrillogenesis of Alzheimer Aβ peptides with selected substitution of charged residues. J. Mol. Biol. 244, 64-73.
51. Pike, C. J., Walencewicz-Wasserman, A. J., Kosmoski, J., Cribbs, D. H., Glabe, C. G., and Cotman, C. W. (1995) Structure-activity analyses of β-amyloid peptides: Contributions of the β25-35 region to aggregation and neurotoxicity. J. Neurochem. 64, 253-265.
52. Mason, R. P., Estermyer, J. D., Kelly, J. F., and Mason, P. E. (1996) Alzheimer's disease amyloid β peptide 25-35 is localized in the membrane hydrocarbon core: X-ray diffraction analysis. Biochem. Biophys. Res. Commun. 222, 78-82.
53. Soto, C., and Frangione, B. (1995) Two conformational states of amyloid β-peptide: Implications for the pathogenesis of Alzheimer's disease. Neurosci. Lett. 186, 115-118.
54. Soto, C., and Castaño, E. M. (1996) The conformation of Alzheimer's β peptide determines the rate of amyloid formation and its resistance to proteolysis. Biochem. J. 314, 701-707.
55. Soto, C., Castaño, E. M., Kumar, R. A., Beavis, R. C., and Frangione, B. (1995) Fibrillogenesis of synthetic amyloid-β peptides is dependent on their initial secondary structure. Neurosci. Lett. 200, 105-108.
56. Terzi, E., Holzemann, G., and Seelig, J. (1995) Self-association of β-amyloid peptide (1-40) in solution and binding to lipid membranes. J. Mol. Biol. 252, 633-642.
57. Tomski, S. J., and Murphy, R. M. (1992) Kinetics of aggregation of synthetic β-amyloid peptide. Arch. Biochem. Biophys. 294, 630-638.
58. M1-containing membranes. FEBS Lett. 402, 95-98.
59. Wood, S. J., MacKenzie, L., Maleeff, B., Hurle, M. R., and Wetzel, R. (1996) Selective inhibition of Aβ fibril formation. J. Biol. Chem. 271, 4086-4092.
60. Wood, S. J., Maleeff, B., Hart, T., and Wetzel, R. (1996) Physical, morphological and functional differences between pH 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Aβ. J. Mol. Biol. 256, 870-877.
61. May, P. C., Gitter, B. D., Waters, D. C., Simmons, L. K., Becker, G. W., Small, J. S., and Robison, P. M. (1992) β-Amyloid peptide in vitro toxicity: lot-to-lot variability. Neurobiol. Aging 13, 605-607.
62. 1H NMR of Aβ amyloid peptide congeners in water solution. Conformational changes correlate with plaque competence. Biochemistry 34, 5191-5200.
63. Sticht, H., Bayer, P., Willbold, D., Dames, S., Hilbich, C., Beyreuther, K., Frank, R. W., and Rösch, P. (1995) Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease. Eur. J. Biochem. 233, 293-298.
64. Stine, W. B., Snyder, S. W., Ladror, U. L., Wade, W. S., Stewart, K., Miller, M. F., Perun, T. J., Holzman, T. F., and Krafft, G. A. (1996) The nanometer-scale structure of amyloid β visualized by atomic force microscopy. J. Protein Chem. 15, 193-203.
65. Snyder, S. W., Wang, G. T., Barrett, L., Ladror, U. S., Casuto, D., Lee, C. M., Krafft, G. A., Holzman, R. B., and Holzman, T. F. (1994) Complement C1q does not bind monomeric β-amyloid. Exp. Neurol. 128, 136-142.
66. Selkoe, D. J. (1994) Normal and abnormal biology of the β-amyloid precursor protein. Annu. Rev. Neurosci. 17, 489-517.
67. Yankner, B. A. (1996) Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16, 921-932.
68. Arispe, N., Rojas, E., and Pollard, H. B. (1993) Alzheimer disease amyloid β protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc. Natl. Acad. Sci. U.S.A. 90, 567-571.
69. Arispe, N., Pollard, H. B., and Rojas, E. (1993) Giant multilevel cation channels formed by Alzheimer disease amyloid β-protein [AβP-(1-40)] in bilayer membranes. Proc. Natl. Acad. Sci. U.S.A. 90, 10573-10577.
70. Mattson, M. P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I., and Rydel, R. E. (1992) β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376-389.
71. 2+ homeostasis in Alzheimer's disease. Trends Neurosci. 16, 409-414.
72. Prehn, J. H. M., Bindokas, V. P., Jordan, J., Galindo, M. F., Ghadge, G. D., Roos, R. P., Boise, L. H., Thompson, C. B., Krajewski, S., Reed, J. C., and Miller, R. J. (1996) Protective effect of transforming growth factor-β1 on β-amyloid neurotoxicity in rat hippocampal neurons. Mol. Pharmacol. 49, 319-328.
73. 2+-dependent late phase. J. Neurochem. 67, 2074-2078.
74. Zhou, Y., Gopalakrishnan, V., and Richardson, J. S. (1996) Actions of neurotoxic β-amyloid on calcium homeostasis and viability of PC 12 cells are blocked by antioxidants but not by calcium channel antagonists. J. Neurochem. 67, 1419-1425.
75. Behl, C., Davis, J. B., Klier, F. G., and Schubert, D. (1994) Amyloid β peptide induces necrosis rather than apoptosis. Brain Res. 645, 253-264.
76. Loo, D. T., Copani, A., Pike, C. J., Whittemore, E. R., Walencewicz, A. J., and Cotman, C. W. (1993) Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. U.S.A. 90, 7951-7955.
77. Takashima, A., Noguchi, K., Sato, K., Hoshino, T., and Imahori, K. (1993) Tau protein kinase I is essential for amyloid β-protein-induced neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 90, 7789-7793.
78. Lambert, M. P., Stevens, G., Sabo, S., Barber, K., Wang, G., Wade, W., Krafft, G., Snyder, S., Holzman, T. F., and Klein, W. L. (1994) Beta-A4-evoked degeneration of differentiated SH-SY5Y human neuroblastoma cells. J. Neurosci. Res. 39, 377-385.
79. Cotman, C. W., and Anderson, A. J. (1995) A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol. Neurobiol. 10, 19-45.
80. Li, Y.-P., Bushnell, A. F., Lee, C.-M., Perlmutter, L. S., and Wong, S. K.-F. (1996) β-Amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells. Brain Res. 738, 196-204.
81. Pike, C. J., Balázs, R., and Cotman, C. W. (1996) Attenuation of β-amyloid neurotoxicity in vitro by potassium-induced depolarization. J. Neurochem. 67, 1774-1777.
82. Lassmann, H., Bancher, C., Breitschopf, H., Wegiel, J., Bobinski, M., Jellinger, K., and Wisniewski, H. M. (1995) Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol. 89, 35-41.
83. Gschwind, M., and Huber, G. (1995) Apoptotic cell death induced by β-amyloid peptide is cell type dependent. J. Neurochem. 65, 292-300.
84. Bowling, A. C., and Beal, M. F. (1995) Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci. 56, 1151-1171.
85. Kumar, U., Dunlop, D. M., and Richardson, J. S. (1994) Mitochondria from Alzheimer's fibroblasts show decreased uptake of calcium and increased sensitivity to free radicals. Life Sci. 54, 1855-1860.
86. Mutisya, E. M., Bowling, A. C., and Beal, M. F. (1994) Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J Neurochem. 63, 2179-2184.
87. Busciglio, J., and Yankner, B. A. (1995) Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 378, 776-779.
88. Ledesma, M. D., Bonay, P., Colaco, C., and Avila, J. (1994) Analysis of microtubule-associated protein T glycation in paired helical filaments. J. Biol. Chem. 269, 21614-21619.
89. Smith, M. A., Taneda, S., Richey, P. L., Miyata, S., Yan, S.-D., Stern, D., Sayre, L. M., Monnier, V. M., and Perry, G. (1994) Advanced Maillard reaction products are associated with Alzheimer disease pathology. Proc. Natl. Acad. Sci. U.S.A. 91, 5710-5714.
90. Smith, M. A., Kutty, R. K., Richey, P. L., Yan, S.-D., Stern, D., Chader, G. J., Wiggert, B., Petersen, R. B., and Perry, G. (1994) Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer disease. Am. J. Pathol. 145, 42-47.
91. Yan, S.-D., Chen, X., Schmidt, A.-M., Brett, J., Godman, G., Zou, Y.-S., Scott, C. W., Caputo, C., Frappier, T., Smith, M. A., Perry, G., Yen, S.-H., and Stern, D. (1994) Glycated τ protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc. Natl. Acad. Sci. U.S.A. 91, 7787-7791.
92. Vitek, M. P., Bhattacharya, K., Glendening, J. M., Stopa, E., Vlassara, H., Bucala, R., Manogue, K., and Cerami, A. (1994) Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 91, 4766-4770.
93. Hensley, K., Hall, N., Subramanian, R., Cole, P., Harris, M., Aksenov, M., Aksenova, M., Gabbita, S. P., Wu, J. F., Carney, J. M., Lovell, M., Markesbery, W. R., and Butterfield, D. A. (1995) Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65, 2146-2156.
94. Smith, M. A., Rudnicka-Nawrot, M., Richey, P. L., Praprotnik, D., Mulvihill, P., Miller, C. A., Sayre, L. M., and Perry, G. (1995) Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. J. Neurochem. 64, 2660-2666.
95. Smith, M. A., Sayre, L. M., Monnier, V. M., and Perry, G. (1995) Radical AGEing in Alzheimer's disease. Trends Neurosci. 18, 172-176.
96. Smith, M. A., Perry, G., Richey, P. L., Sayre, L. M., Anderson, V. E., Beal, M. F., and Kowall, N. (1996) Oxidative damage in Alzheimer's. Nature 382, 120-121.
97. Smith, M. A., Harris, P. L. R., Sayre, L. M., Beckman, J. S., and Perry, G. (1997) Widespread oxygen radical damage in Alzheimer disease. J. Neurosci. 17, 2653-2657.
98. Montine, K. S., Olson, S. J., Amarnath, V., Whetsell, W. O., Jr., Graham, D. G., and Montine, T. J. (1997) Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4. Am. J. Pathol. 150, 437-443.
99. Sayre, L. M., Zelasko, D. A., Harris, P. L. R., Perry, G., Salomon, R. G., and Smith, M. A. (1997) 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem. 68, 2092-2097.
100. Mattson, M. P., and Goodman, Y. (1995) Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium. Brain Res. 676, 219-224.
101. Behl, C., Davis, J., Lesley, R., and Schubert, D. (1994) Hydrogen peroxide mediates amyloid protein toxicity. Cell 77, 817-827.
102. Kumar, U., Dunlop, D. M., and Richardson, J. S. (1994) The acute neurotoxic effect of β-amyloid on mature cultures of rat hippocampal neurons is attenuated by the anti-oxidant U-78517F. Int. J. Neurosci. 79, 185-190.
103. Bruce, A. J., Malfroy, B., and Baudry, M. (1996) β-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger. Proc. Natl. Acad. Sci. U.S.A. 93, 2312-2316.
104. Sagara, Y., Dargusch, R., Klier, F. G., Schubert, D., and Behl, C. (1996) Increased antioxidant enzyme activity in amyloid β protein-resistant cells. J. Neurosci. 16, 497-505.
105. Puttfarcken, P. S., Manelli, A. M., Neilly, J., and Frail, D. E. (1996) Inhibition of age-induced β-amyloid neurotoxicity in rat hippocampal cells. Exp. Neurol. 138, 73-81.
106. 2 generation. J. Neurochem. 67, 1595-1606.
107. 25-35 peptide-mediated neurotoxicity in rat hippocampal cultures. J. Neurosci. Res. 39, 494-505.
108. Butterfield, D. A., Hensley, K., Harris, M., Mattson, M., and Carney, J. (1994) β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: Implications to Alzheimer's disease. Biochem. Biophys. Res. Commun. 200, 710-715.
109. Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., and Butterfield, D. A. (1994) A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 91, 3270-3274.
110. Harris, M. E., Hensley, K., Butterfield, D. A., Leedle, R. A., and Carney, J. M. (1995) Direct evidence of oxidative injury produced by the Alzheimer's β-amyloid peptide (1-40) in cultured hippocampal neurons. Exp. Neurol. 131, 193-202.
111. Brot, N., and Weissbach, H. (1983) Biochemistry and physiological role of methionine sulfoxide residues in proteins. Arch. Biochem. Biophys. 223, 271-281.
112. Shen, C.-L., Fitzgerald, M. C., and Murphy, R. M. (1994) Effect of acid predissolution on fibril size and fibril flexibility of synthetic β-amyloid peptide. Biophys. J. 67, 1238-1246.
113. Lorenzo, A., Matsudaira, P., and Yankner, B. A. (1993) The role of oxidation in the neurotoxicity of beta amyloid. Soc. Neurosci. Abstr. 19, 184.
114. Bobrowski, K., Schöneich, C., Holcman, J., and Asmus, K.-D. (1991) Hydroxyl radical induced decarboxylation of methionine-containing peptides. Influence of peptide sequence and net charge. J. Chem. Soc., Perkin Trans. 2 353-362.
115. Schöneich, C., and Wang, J. (1996) Oxidation of methionine peptides by Fenton systems: the importance of peptide sequence, neighboring groups and EDTA. J. Chem. Soc., Perkin Trans. 2 915-924.
116. Stadtman, E. R. (1992) Protein oxidation and aging. Science 257, 1220-1224.
117. Stadtman, E. R. (1993) Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annu. Rev. Biochem. 62, 797-821.
118. Multhaup, G., Schlicksupp, A., Hesse, L., Beher, D., Ruppert, T., Masters, C. L., and Beyreuther, K. (1996) The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I). Science 271, 1406-1409.
119. Sayre, L. M. (1996) Alzheimer's precursor protein and the use of bathocuproine for determining reduction of copper(II). Science 274, 1933-1934.
120. Klegeris, A., Walker, D. G., and McGeer, P. L. (1994) Activation of macrophages by Alzheimer β amyloid peptide. Biochem. Biophys. Res. Commun. 199, 984-991.
121. McLaurin, J., and Chakrabartty, A. (1996) Membrane disruption by Alzheimer β-amyloid peptides mediated through specific binding to either phospholipids or gangliosides. J. Biol. Chem. 271, 26482-26489.
122. Schubert, D., Behl, C., Lesley, R., Brack, A., Dargusch, R., Sagara, Y., and Kimura, H. (1995) Amyloid peptides are toxic via a common oxidative mechanism. Proc. Natl. Acad. Sci. U.S.A. 92, 1989-1993.
123. May, P. C., Boggs, L. N., and Fuson, K. S. (1993) Neurotoxicity of human amylin in rat primary hippocampal cultures: Similarity to Alzheimer's disease amyloid-β neurotoxicity. J. Neurochem. 61, 2330-2333.
124. Lorenzo, A., Razzaboni, B., Weir, G. C., and Yankner, B. A. (1994) Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 386, 756-760.
125. Frey, P., Lis, M., Ristig, D., Strauss, U., Amstutz, R., Swoboda, R., and Staufenbiel, M. (1994) Studies on the mechanism of β/A toxicity. Neurobiol. Aging 15 (Suppl. 1), S19.
126. Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., Migheli, A., Nawroth, P., Stern, D., and Schmidt, A. M. (1996) RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382, 685-691.
127. El Khoury, J., Hickman, S. E., Thomas, C. A., Cao, L., Silverstein, S. C., and Loike, J. D. (1996) Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils. Nature 382, 716-719.
128. Zhang, C., Lambert, M. P., Bunch, C., Barber, K., Wade, W., Krafft, G. A., and Klein, W. L. (1994) Focal adhesion kinase expressed by nerve cell lines shows increased tyrosine phosphorylation in response to Alzheimer's Aβ peptide. J. Biol. Chem. 269, 25247-25250.
129. Zhang, C., Qui, H. E., Krafft, G. A., and Klein, W. L. (1996) Protein kinase C and F-actin are essential for stimulation of neuronal FAK tyrosine phosphorylation by G-proteins and Aβ protein. FEBS Lett. 386, 185-188.
130. Zhang, C., Qui, H. E., Krafft, G. A., and Klein, W. L. (1996) Aβ peptide enhances FAK/Fyn association in a rat CNS cell line. Neurosci. Lett. 211, 187-190.
131. Luo, Y., Sunderland, T., and Wolozin, B. (1996) Physiologic levels of beta-amyloid activate phosphatidylinositol 3-kinase with the involvement of tyrosine phosphorylation. J. Neurochem. 67, 978-987.
132. Berg, M. M., and Klein, W. L. (1996) Rapid impact of Alzheimer's Aβ peptide on focal adhesion signaling proteins. Soc. Neurosci. Abstr. 22, 486.
133. Ishiguro, K., Shiratsuchi, A., Sato, S., Omori, A., Arioka, M., Kobayashi, S., Uchida, T., and Imahori, K. (1993) Glycogen synthase kinase 3β is identical to tau protein kinase I generating several epitopes of paired helical filaments. FEBS Lett. 325, 167-172.
134. Hanger, D. P., Hughes, K., Woodgett, J. R., Brion, J.-P., and Anderton, B. H. (1992) Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci. Lett. 147, 58-62.
135. Lovestone, S., Reynolds, C. H., Latimer, D., Davis, D. R., Anderton, B. H., Gallo, J. M., Hanger, D., Mulot, S., Marquardt, B., Stabel, S., Woodgett, J. R., and Miller, C. C. J. (1994) Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr. Biol. 4, 1077-1086.
136. Busciglio, J., Lorenzo, A., Yeh, J., and Yankner, B. A. (1995) β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14, 879-888.
137. Lehtonen, J. Y., Holopainen, J. M., and Kinnunen, P. K. (1996) Activation of phospholipase A2 by amyloid beta-peptides in vitro. Biochemistry 35, 9407-9714.
138. Goodman, Y., Steiner, M. R., Steiner, S. M., and Mattson, M. P. (1994) Nordihydroguaiaretic acid protects hippocampal neurons against amyloid β-peptide toxicity, and attenuates free radical and calcium accumulation. Brain Res. 654, 171-176.
139. Hoshi, M., Takashima, A., Noguchi, K., Murayama, M., Sato, M., Kondo, S., Saitoh, Y., Ishiguro, K., Hoshino, T., and Imahori, K. (1996) Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3β in brain. Proc. Natl. Acad. Sci. U.S.A. 93, 2719-2723.
140. Kaneko, I., Yamada, N., Sakuraba, Y., Kamenosono, M., and Tutumi, S. (1995) Suppression of mitochondrial succinate dehydrogenase, a primary target of beta-amyloid, and its derivative racemized at Ser residue. J. Neurochem. 65, 2585-2593.
141. Thomas, T., Thomas, G., McLendon, C., Sutton, T., and Mullan, M. (1996) β-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature 380, 168-171.